Neutropenia Induced by Drugs Used in Psychiatric Treatment: A Case Report
Abstract
Keywords
Supporting Institution
Project Number
References
- 1. Bonilla MA. Disorders of white blood cells. In Manual of Pediatric Hematology and Oncology, Lanzkowsky ed, 5th edition, Amsterdam, Elsevier, 2011, p:272-320
- 2. Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp. 2008; 23(1): 27-41
- 3. Uetrecht JP. Reactive metabolites and agranulocytosis. Eur J Haematol Suppl. 1996; 60: 83-88
- 4. Brouns R, De Deyn PP. Neurological complications in renal failure : a review. Clin Neurol Neurosurg. 2004; 107 (1): 1-16. doi: 10.1016/j.clineuro.2004.07.012.
- 5. Nair P, Lippmann S. Is leukopenia associated with divalproex and/or quetiapine? Can J Psychiatry. 2003; 48: 65-66
- 6. Bartels M, van Solinge WW, den Breeijen HJ, Bierings MB, Coffer PJ, Egberts TCG. Valproic acid treatment is associated with altered leukocyte subset development. J Clin Psychopharmacol. 2012; 32: 832–4
- 7. Rahman A, Mican LM, Fischer C, Campbell AH. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Ann Pharmacother. 2009; 43: 822-830
- 8. Petrini M, Azzarà A. Lithium in the treatment of neutropenia. Curr Opin Hematol. 2012; 19(1): 52-7. doi: 10.1097/MOH.0b013e32834da93b
Details
Primary Language
English
Subjects
Emergency Medicine
Journal Section
Case Report
Authors
Liljana Mehmetaj
0000-0002-7049-9914
Türkiye
Yasin Ugur
0000-0002-8368-8642
Türkiye
Ertan Sonmez
0000-0003-1774-3276
Türkiye
Basar Cander
0000-0002-3308-5843
Türkiye
Publication Date
August 30, 2022
Submission Date
August 16, 2022
Acceptance Date
August 22, 2022
Published in Issue
Year 2022 Volume: 4 Number: 2